196 related articles for article (PubMed ID: 11702050)
1. Kinetic analysis of [(11)C]MP4A using a high-radioactivity brain region that represents an integrated input function for measurement of cerebral acetylcholinesterase activity without arterial blood sampling.
Nagatsuka Si S; Fukushi K; Shinotoh H; Namba H; Iyo M; Tanaka N; Aotsuka A; Ota T; Tanada S; Irie T
J Cereb Blood Flow Metab; 2001 Nov; 21(11):1354-66. PubMed ID: 11702050
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomographic measurement of brain acetylcholinesterase activity using N-[(11)C]methylpiperidin-4-yl acetate without arterial blood sampling: methodology of shape analysis and its diagnostic power for Alzheimer's disease.
Tanaka N; Fukushi K; Shinotoh H; Nagatsuka S; Namba H; Iyo M; Aotsuka A; Ota T; Tanada S; Irie T
J Cereb Blood Flow Metab; 2001 Mar; 21(3):295-306. PubMed ID: 11295884
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of simplified kinetic analyses for measurement of brain acetylcholinesterase activity using N-[11C]Methylpiperidin-4-yl propionate and positron emission tomography.
Sato K; Fukushi K; Shinotoh H; Nagatsuka S; Tanaka N; Aotsuka A; Ota T; Shiraishi T; Tanada S; Iyo M; Irie T
J Cereb Blood Flow Metab; 2004 Jun; 24(6):600-11. PubMed ID: 15181367
[TBL] [Abstract][Full Text] [Related]
4. Kinetic modeling of N-[11C]methylpiperidin-4-yl propionate: alternatives for analysis of an irreversible positron emission tomography trace for measurement of acetylcholinesterase activity in human brain.
Koeppe RA; Frey KA; Snyder SE; Meyer P; Kilbourn MR; Kuhl DE
J Cereb Blood Flow Metab; 1999 Oct; 19(10):1150-63. PubMed ID: 10532640
[TBL] [Abstract][Full Text] [Related]
5. A simple method for the detection of abnormal brain regions in Alzheimer's disease patients using [11C]MP4A: comparison with [123I]IMP SPECT.
Ota T; Shinotoh H; Fukushi K; Nagatsuka S; Namba H; Iyo M; Aotsuka A; Tanaka N; Sato K; Shiraishi T; Tanada S; Arai H; Irie T
Ann Nucl Med; 2004 May; 18(3):187-93. PubMed ID: 15233279
[TBL] [Abstract][Full Text] [Related]
6. Dementia with Lewy bodies can be well-differentiated from Alzheimer's disease by measurement of brain acetylcholinesterase activity-a [11C]MP4A PET study.
Shimada H; Hirano S; Sinotoh H; Ota T; Tanaka N; Sato K; Yamada M; Fukushi K; Irie T; Zhang MR; Higuchi M; Kuwabara S; Suhara T
Int J Geriatr Psychiatry; 2015 Nov; 30(11):1105-13. PubMed ID: 26280153
[TBL] [Abstract][Full Text] [Related]
7. Brain acetylcholinesterase activity: validation of a PET tracer in a rat model of Alzheimer's disease.
Irie T; Fukushi K; Namba H; Iyo M; Tamagami H; Nagatsuka S; Ikota N
J Nucl Med; 1996 Apr; 37(4):649-55. PubMed ID: 8691261
[TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography: quantitative measurement of brain acetylcholinesterase activity using radiolabeled substrates.
Namba H; Fukushi K; Nagatsuka S; Iyo M; Shinotoh H; Tanada S; Irie T
Methods; 2002 Jul; 27(3):242-50. PubMed ID: 12183113
[TBL] [Abstract][Full Text] [Related]
9. Voxel-Based Acetylcholinesterase PET Study in Early and Late Onset Alzheimer's Disease.
Hirano S; Shinotoh H; Shimada H; Ota T; Sato K; Tanaka N; Zhang MR; Higuchi M; Fukushi K; Irie T; Kuwabara S; Suhara T
J Alzheimers Dis; 2018; 62(4):1539-1548. PubMed ID: 29562505
[TBL] [Abstract][Full Text] [Related]
10. In vivo evaluation of N-[18F]fluoroethylpiperidin-4ylmethyl acetate in rats compared with MP4A as a probe for measuring cerebral acetylcholinesterase activity.
Kikuchi T; Okamura T; Zhang MR; Fukushi K; Irie T
Synapse; 2010 Mar; 64(3):209-15. PubMed ID: 19862687
[TBL] [Abstract][Full Text] [Related]
11. Effect of radiolabeled metabolite elimination from the brain on the accuracy of cerebral enzyme activity estimation using positron emission tomography with substrate tracers.
Ohya T; Okamura T; Nagai Y; Fukushi K; Irie T; Suhara T; Zhang MR; Fukumura T; Kikuchi T
Neuroimage; 2011 Jun; 56(3):1105-10. PubMed ID: 21324368
[TBL] [Abstract][Full Text] [Related]
12. In-vivo measurements of regional acetylcholine esterase activity in degenerative dementia: comparison with blood flow and glucose metabolism.
Herholz K; Bauer B; Wienhard K; Kracht L; Mielke R; Lenz MO; Strotmann T; Heiss WD
J Neural Transm (Vienna); 2000; 107(12):1457-68. PubMed ID: 11458998
[TBL] [Abstract][Full Text] [Related]
13. Human cerebral acetylcholinesterase activity measured with positron emission tomography: procedure, normal values and effect of age.
Namba H; Iyo M; Fukushi K; Shinotoh H; Nagatsuka S; Suhara T; Sudo Y; Suzuki K; Irie T
Eur J Nucl Med; 1999 Feb; 26(2):135-43. PubMed ID: 9933347
[TBL] [Abstract][Full Text] [Related]
14. PET measurement of cerebral acetylcholine esterase activity without blood sampling.
Herholz K; Lercher M; Wienhard K; Bauer B; Lenz O; Heiss WD
Eur J Nucl Med; 2001 Apr; 28(4):472-7. PubMed ID: 11357497
[TBL] [Abstract][Full Text] [Related]
15. Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease.
Iyo M; Namba H; Fukushi K; Shinotoh H; Nagatsuka S; Suhara T; Sudo Y; Suzuki K; Irie T
Lancet; 1997 Jun; 349(9068):1805-9. PubMed ID: 9269216
[TBL] [Abstract][Full Text] [Related]
16. N-[18F]fluoroethyl-4-piperidyl acetate ([18F]FEtP4A): A PET tracer for imaging brain acetylcholinesterase in vivo.
Zhang MR; Furutsuka K; Maeda J; Kikuchi T; Kida T; Okauchi T; Irie T; Suzuki K
Bioorg Med Chem; 2003 Jun; 11(12):2519-27. PubMed ID: 12757720
[TBL] [Abstract][Full Text] [Related]
17. Spatial distributions of cholinergic impairment and neuronal hypometabolism differ in MCI due to AD.
Richter N; Nellessen N; Dronse J; Dillen K; Jacobs HIL; Langen KJ; Dietlein M; Kracht L; Neumaier B; Fink GR; Kukolja J; Onur OA
Neuroimage Clin; 2019; 24():101978. PubMed ID: 31422337
[TBL] [Abstract][Full Text] [Related]
18. [11C]-MP4A PET cholinergic measurements in amnestic mild cognitive impairment, probable Alzheimer's disease, and dementia with Lewy bodies: a Bayesian method and voxel-based analysis.
Marcone A; Garibotto V; Moresco RM; Florea I; Panzacchi A; Carpinelli A; Virta JR; Tettamanti M; Borroni B; Padovani A; Bertoldo A; Herholz K; Rinne JO; Cappa SF; Perani D
J Alzheimers Dis; 2012; 31(2):387-99. PubMed ID: 22596267
[TBL] [Abstract][Full Text] [Related]
19. Acetylcholinesterase imaging: its use in therapy evaluation and drug design.
Shinotoh H; Fukushi K; Nagatsuka S; Irie T
Curr Pharm Des; 2004; 10(13):1505-17. PubMed ID: 15134572
[TBL] [Abstract][Full Text] [Related]
20. Effect of donepezil on brain acetylcholinesterase activity in patients with AD measured by PET.
Shinotoh H; Aotsuka A; Fukushi K; Nagatsuka S; Tanaka N; Ota T; Tanada S; Irie T
Neurology; 2001 Feb; 56(3):408-10. PubMed ID: 11171913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
